Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 6, 2000, Pages 1877-1880

  McColley, Susanna A ^a,b   Stellmach, Veronica ^a   Boas, Steven R ^a   Jain, Manu ^a   Crawford, Susan E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SERUM;

EID: 0034047708     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.6.9905022     Document Type: Article

References (22)

1. 1. Kosorok, M. R., W. H. Wei, and P. M. Farrell. 1996. The incidence of cystic fibrosis. Stat. Med. 15:449-462.
2. 2. Khan, T. Z., J. S. Wagener, T. Boat, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
3. 3. Accurso, F. J. 1997. Early pulmonary disease in cystic fibrosis. Curr. Opin. Pulm. Med. 3:400-403.
4. 4. Crawford, S., V. Stellmach, S. McColley, J. Jacobitz, C. Backer, and N. Bouck. 1997. Elevated inducer of angiogenesis and increased microvascular density suggest a role for neovascularization in cystic fibrosis. Pediair. Pulmonol. Suppl. 14:296.
5. 5. Jackson, J. R., M. P. Seed, C. H. Kirscher, D. A. Willoughby, and J. D. Winkler. 1997. The codependence of angiogenesis and chronic inflammation. FASEB J. 11:457-465.
6. 6. Amoroso, A., F. Del Porto, C. Di Monaco, P. Manfredini, and A. Afeltra. 1997. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur. Rev. Med. Pharmacol. Sci. 1:17-25.
7. 7. Klagsburn, M., and P. A. D'Amore. 1997. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7:259-270.
8. 8. Cystic Fibrosis Foundation Patient Registry. 1997. Annual Data Report. September 1998. Cystic Fibrosis Foundation. Bethesda, MD.
9. 9. Neglia, J. P., S. C. FitzSimmons, P. Maisonneuve, M. H. Schoni, F. Schoni-Affolter, M. Corey, and A. B. Lowenfels. 1995. The risk of cancer among patients with cystic fibrosis. N. Engl. J. Med. 332:494-498.
10. 10. Dvorak, H. F., L. F. Brown, M. Detmanr, and A. M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
11. 11. Rosenstein, B. J., and G. R. Cutting. 1998. The diagnosis of cystic fibrosis: a consensus statement. J. Pediatr. 132:589-595.
12. 12. American Thoracic Society. 1995. Standardization of spirometry: 1994 update. ATS statement. Am. J. Respir. Crit. Care Med. 152:1107-1136.
13. 13. Weng, T., and H. Levison. 1969. Standards of pulmonary function in children. Am. Rev. Respir. Dis. 99:879-894.
14. 14. Schoenberg, J. B., G. J. Beck, and A. Bouhuys. 1978. Growth and decay of pulmonary function in healthy blacks and whites. Kespir. Physiol. 367-393.
15. 15. Stern, R. C. 1998. Inpatient treatment of cystic fibrosis pulmonary disease. In D. M. Orenstein and R. C. Stern, editors. Treatment of the Hospitalized Cystic Fibrosis Patient. Marcel Dekker, New York. 79-133.
16. 16. Hyodo, I., T. Doi, H. Endo, Y. Hosokawa, Y. Nishikawa, M. Tanimizu, K. Jinno, and Y. Kotani. 1998. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur. J. Cancer 34:2041-2045.
17. 17. Kikuchi, K., M. Kubo, T. Kadono, N. Yazawa, H. Ihn, and K. Tamaki. 1998. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br. J. Dermatol. 139:1049-1051.
18. 18. Taichman, N. S., S. Young, A. T. Cruchley, P. Taylor, and E. Paleolog. 1997. Human neutrophils secrete vascular endothelial growth factor. J. Leukoc. Biol. 62:397-400.
19. 19. Crawford, S. E., V. Stellmach, J. E. Murphy-Ullrich, S. M. F. Ribeiro, G. P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF B-1 in vivo. Cell 93:1159-1170.
20. 20. Francouer, C., and M. Denis. 1995. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 19:587-598.
21. 21. Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocyles mediates angiogenesis. Am. J. Palhol. 144:820-828.
22. 22. Paleolog, E. M. 1996. Angiogenesis: a critical process in the pathogenesis of RA: a role for VEGF? Br. J. Rheumatol. 35:917-920.